Skip to content

Clinical trials

Hemorrhage trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: China Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20082
20091
20102
20111
20121
20134
20148
20155
20164
20176
20188
20197
20205
20213
20226
20238
20242
202511
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Unknown status28
Recruiting20
Not yet recruiting5
Withdrawn3
Terminated2
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences, Fuwai Hospital4
Chinese University of Hong Kong4
Xijing Hospital4
Beijing Tiantan Hospital3
Peking Union Medical College Hospital3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Southwest Hospital, China3
Air Force Military Medical University, China2
Beijing Anzhen Hospital2
Chinese PLA General Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage97
Stroke9
Cerebral Hemorrhage7
Liver Cirrhosis6
Acute Coronary Syndrome4
Atrial Fibrillation4
Cardiovascular Diseases4
Cerebrovascular Disorders4
Intracranial Hemorrhages4
Myocardial Infarction4

Trials

Showing 51 to 75 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.